ACTIVE HALF-LIFE
12-36 hours
CLASSIFICATION
Peptide Hormone
ACNE
No
WATER RETENTION
No
HBR
No
HEPATOTOXICITY
No
AROMATIZATION
No
MANUFACTURER
Ferring
WAREHOUSE
International Warehouse 2
SUBSTANCE
Human Menopausal Gonadotropin
Introducing Menogon 75IU Injection, widely known as hMG, a vital solution for addressing infertility in women. This hormone-rich medication, also referred to as Menotropin, plays a crucial role in stimulating ovarian egg production, especially for those facing ovarian failure. Sourced from the urine of postmenopausal women, Menogon is enriched with elevated levels of follicle-stimulating hormone (FSH), luteinizing hormone (LH), and other essential gonadotropins. Administered via intramuscular injection, it is designed to support your journey to conception.
While using Menogon 75IU Injection, it?s important to be aware of potential side effects, which may include headaches, mood fluctuations, fatigue, weight gain, swelling at the injection site, breast enlargement, and tenderness. One notable concern is abdominal discomfort linked to ovarian hyperstimulation syndrome (OHSS), a condition that can arise from excessive egg production leading to swollen ovaries. Additionally, there may be an increased risk of conceiving twins following treatment. Prior to starting this medication, it's crucial to consult with your healthcare provider regarding any of the following medical conditions:
- Allergies to menotropins or gonadotropins
- Vaginal bleeding
- Ovarian cysts
Dosage will be customized based on individual needs, ensuring the best possible outcomes. For optimal effectiveness, it is recommended to time conception with intercourse within 12 to 36 hours after receiving the Menogon 75IU Injection. If the first treatment cycle is unsuccessful, a thorough reassessment is vital. Should ovulation not occur after three treatment cycles, please reach out to your doctor to discuss any concerns regarding the Menogon 75IU Injection.